Stay updated on Risdiplam in SMA Type 2/3: Clinical Trial

Sign up to get notified when there's something new on the Risdiplam in SMA Type 2/3: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risdiplam in SMA Type 2/3: Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    - The page now includes new Location sections and site entries (California, New York, Rio de Janeiro, Alberta, Ontario, Quebec, Lazio, Liguria, Lombardy, Moscow Oblast, Barcelona) and removes several regional location blocks. Revision identifiers updated (v3.3.2 to v3.3.3).
    Difference
    0.8%
    Check dated 2025-12-24T19:54:25.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Added note that publications are automatically filled from PubMed and may not all pertain to the study. The revision label was updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T21:09:54.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Removed an operational government funding notice; study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T18:54:30.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The update shows minor changes to the page, such as revised Study Record Dates and small formatting adjustments; there are no edits to core study details, eligibility criteria, arms, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T09:52:59.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Update to version v3.2.0, addition of the Spinal muscular atrophy resource, and a government funding/status notice.
    Difference
    1%
    Check dated 2025-10-05T14:32:39.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Page updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.
    Difference
    0.1%
    Check dated 2025-09-28T09:50:46.000Z thumbnail image

Stay in the know with updates to Risdiplam in SMA Type 2/3: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risdiplam in SMA Type 2/3: Clinical Trial page.